Skip to main content Accessibility help
×
Home
Hostname: page-component-559fc8cf4f-28jzs Total loading time: 0.4 Render date: 2021-03-03T15:39:32.301Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Industry and Academic Medicine: A Dangerous Liaison?

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this article
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1.Lenzer, J.Alteplase for stroke: money and optimistic claims buttressthe brain attack: campaign. Br Med J 2002;324:723729.CrossRefGoogle ScholarPubMed
2.Editorial. The invisible hand of the marketing department. CMAJ 2002;167:5.Google ScholarPubMed
3.Wazana, A.Physicians and the pharmaceutical industry. JAMA 2000;283:373380.CrossRefGoogle ScholarPubMed
4.Choudhry, NK, Stelfox, HT, Detsky, AS.Relationships betweenauthors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612617.CrossRefGoogle ScholarPubMed
5.Drazen, JM, Curfman, GD.Financial associations of authors. N Engl J Med 2002;346:19011902.CrossRefGoogle ScholarPubMed
6.Relman, AS.Financial associations of authors. N Engl J Med 2002;347:1043.Google ScholarPubMed
7.Montaner, JSG, O’Shaughnessy, MV, Schechter, MT.Industry-sponsored clinical research: a double-edged sword. Lancet 2001;358:18931894.CrossRefGoogle Scholar
8.Bodenheimer, T.Uneasy alliance-clinical investigators and thepharmaceutical industry. N Engl J Med 2000;324:15391544.CrossRefGoogle Scholar
9.Drazen, JM.Institutions, contracts, and academic freedom. N Engl J Med 2002;347:13621363.CrossRefGoogle Scholar

Full text views

Full text views reflects PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.

Total number of HTML views: 0
Total number of PDF views: 69 *
View data table for this chart

* Views captured on Cambridge Core between September 2016 - 3rd March 2021. This data will be updated every 24 hours.

Access

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Industry and Academic Medicine: A Dangerous Liaison?
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Industry and Academic Medicine: A Dangerous Liaison?
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Industry and Academic Medicine: A Dangerous Liaison?
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *